Inhibition of GSK3α/β impairs the progression of HNSCC

BACKGROUND: Head and neck squamous cell cancer (HNSCC) is one of the most common tumors worldwide and there is an enormous need for innovative therapy approaches. Several recent studies suggest tumor entity specific roles of glycogen synthase kinase 3 (GSK3) in different human cancers, acting as tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulz, Lisa, Pries, Ralph, Lanka, Aruna Sree, Drenckhan, Maren, Rades, Dirk, Wollenberg, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021246/
https://www.ncbi.nlm.nih.gov/pubmed/29963225
http://dx.doi.org/10.18632/oncotarget.25250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021246/
https://www.ncbi.nlm.nih.gov/pubmed/29963225
http://dx.doi.org/10.18632/oncotarget.25250

Ejemplares similares